Anticoagulant
(Redirected from blood thinner)
Jump to navigation
Jump to search
An Anticoagulant is a chemical substance that inhibits coagulation.
- AKA: Blood Thinner.
- Example(s):
- Eliquis,
- …
- Counter-Example(s):
- an Antibiotic,
- an Antiseptic,
- an Antiviral Medication.
- See: Heparin, Blood, Clotting Time, Hematophagy, Leech, Mosquito, Pharmaceutical Drug, Therapy, Thrombosis, Oral Administration.
References
2022
- (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/Anticoagulant Retrieved:2022-7-13.
- Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as sample tubes, blood transfusion bags, heart–lung machines, and dialysis equipment. One of the first anticoagulants, warfarin, was initially approved as a rodenticide. Anticoagulants are closely related to antiplatelet drugs and thrombolytic drugs by manipulating the various pathways of blood coagulation. Specifically, antiplatelet drugs inhibit platelet aggregation (clumping together), whereas anticoagulants inhibit specific pathways of the coagulation cascade, which happens after the initial platelet aggregation but before the formation of fibrin and stable aggregated platelet products. Common anticoagulants include warfarin and heparin.[1]
- ↑ Winslow R, Johnson A (2007-12-10). "Race Is on for the Next Blood Thinner". The Wall Street Journal. p. A12. Retrieved 2008-01-06. ...in a market now dominated by one of the oldest mainstay pills in medicine: the blood thinner warfarin. At least five next-generation blood thinners are in advanced testing to treat or prevent potentially debilitating or life-threatening blood clots in surgery and heart patients. First candidates could reach the market in 2009.